PlainPatent

CPC technology class · A61

A61D - Veterinary Instruments

Veterinary instruments, implements, tools, or methods. 885 US utility patents granted 2015–2025, with the leading assignees and year-by-year grant trajectory.

885
US patents granted
#13/13
in A61
0.1%
A61 class share
+11%
5-yr velocity

The verdict

According to USPTO PatentsView, Veterinary Instruments ranks #474 of 670 CPC technology areas - 885 US patents granted since 2015, with recorded grant volume up 11% over five years.

#474
of 670 CPC technology areas
885
US patents granted, 2015–2025
Imv
leading assignee (23)
+11%
grant velocity, last 5 yrs

How A61D's grant cadence moved

Between 2020–2024, A61D recorded 411 grants versus 371 in 2015–2019 (+11% equal-window velocity). Across complete years, output peaked in 2019 at 95 grants and bottomed in 2015 at 48 (+98% peak-over-trough). Lead assignee IMV Technologies holds 2.6% of the class ; the top three share 6.1%.

Leaderboard read

A61D concentration, lead at 2.6%

IMV Technologies leads this historical grant record at 2.6% of A61D - us corporation assignees hold 59% of class grants (225 of 384). Figures describe granted US utility patents in this CPC subclass, not current investment or legal strength.

Leader's share
2.6%

23 of 885 grants

Top three share
6.1%

of the class's recorded grants

Lead over #2
6

more grants than Inguran, LLC

Where A61D sits inside A61

Among 13 subclasses in A61 (Medical OR Veterinary SCIENCE; Hygiene), A61D ranks #13 and holds 0.1% of the parent class's 646,867 recorded grants. Sibling chips below are the other subclasses in the same parent class, not the nationwide volume/lead-share peers further down.

A61B 162,009 A61K 151,067 A61P 125,535 A61M 57,639 A61F 50,959 A61N 30,889 A61L 25,308 A61Q 14,001

Rising assignees active in A61D

Company-wide grant multiples (2022–2024 vs 2019–2021) among assignees with ≥5 patents in this subclass. Growth is company-wide; class patent counts are subclass-specific.

  1. #1 Cypher Medical, LLC 8.00x 1 → 8 company-wide · 8 in A61D
  2. #2 ABS Global, Inc. 3.13x 8 → 25 company-wide · 7 in A61D
  3. #3 PureWick Corporation 2.23x 13 → 29 company-wide · 11 in A61D
  4. #4 Nova-Tech Engineering, LLC 2.00x 3 → 6 company-wide · 11 in A61D
  5. #5 Attractive Surgical, LLC 2.00x 1 → 2 company-wide · 5 in A61D

A61D grants by year, peak 2019 (95)

US utility-patent grants per year in A61D, 2015–2025 - recent five years are up 11% versus 2015–2019.

406080100 20152016201720182019202020212022202320242025 60

Who leads A61D?

The 12 most active assignees in Veterinary Instruments, Implements, Tools, OR Methods - wider bars mean more grants

patents

What this shows Imv is the most active filer in A61D, holding 23 of the 885 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.

Source USPTO PatentsView, granted utility patents As of 2015–2025 grant years
View data table
Top patent holders in CPC subclass A61D
Rank Company Patents in A61D
#1 IMV Technologies 23
#2 Inguran, LLC 17
#3 Boehringer Ingelheim Vetmedica GMBH 14
#4 Regeneron Pharmaceuticals, Inc. 13
#5 PureWick Corporation 11
#6 Nova-Tech Engineering, LLC 11
#7 Boehringer Ingelheim Animal Health USA Inc. 9
#8 ST Reproductive Technologies, LLC 9
#9 Zoetis Services LLC 8
#10 Vero Biotech Inc. 8
#11 CrossBay Medical, Inc. 8
#12 XY, LLC 8
#13 Cypher Medical, LLC 8
#14 ABS Global, Inc. 7
#15 Aspect Imaging Ltd. 6
#16 Henke-Sass, Wolf GmbH 6
#17 Lely Patent N.V. 5
#18 Merial Inc. 5
#19 Make Ideas, LLC 5
#20 Desvac 5

Footprint here vs. claim strategy

Each dot is a leading A61D assignee, placed by how many patents it holds in this class (horizontal) against its company-wide average claims per patent (vertical) - a read on whether the class is led by broad-but-shallow filers or focused deep-claim players.

Top 14 A61D assignees by class footprint. Bubble size = patents in A61D. Source: USPTO PatentsView (claim depth is company-wide across all classes). Scatter plot of 14 data points (bubble-sized by third dimension). 1015202530 510152025 Patents in A61D Avg claims / patent (company-wide) ImvInguranBoehringer Ingelheim…Regeneron Pharmaceutic…PurewickNova-tech EngineeringBoehringer Ingelheim…St ReproductiveZoetis ServicesVero BiotechCrossbay MedicalXyCypher MedicalAbs Global
Top 14 A61D assignees by class footprint. Bubble size = patents in A61D. Source: USPTO PatentsView (claim depth is company-wide across all classes).

Classes near A61D's 885-grant footprint

Nationwide nearest neighbors for A61D (#474 of 670 by volume ; lead share 2.6%) - not the A61 parent-class siblings above.

Nearest by grant volume

B62L 885 F42D 887 B04C 873 D07B 899

Nearest by lead-assignee share

F16F 2.6% C22F 2.6% G08B 2.6% A45F 2.6%

Questions about A61D

Which company holds the most patents in A61D?
IMV Technologies leads A61D with 23 patents (2.6% of the subclass). By PatentsView assignee type, us corporations account for 59% of class grants.
Which A61D assignees grew fastest recently?
Among assignees with ≥5 grants in A61D, Cypher Medical, LLC shows the highest company-wide grant multiple (8.00x: 1 grants in 2019–2021 → 8 in 2022–2024) while holding 8 patents in this subclass. Growth is company-wide, not class-only.
How does A61D compare inside parent class A61?
Inside A61 (Medical OR Veterinary SCIENCE; Hygiene), A61D ranks #13 of 13 subclasses by grant volume and holds 0.1% of the parent class total. The largest sibling is A61B (162,009 grants).

What to do with this data

A61D in context - here's where to go next.

Figures reflect USPTO PatentsView grant data through 2026-05-15; pending applications not yet granted are not counted.

Methodology - A61D figures are USPTO PatentsView granted-utility totals for this subclass (885 grants in the tracked window).

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.